Make a deal with Eli Lilly and Company
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Known for
47.2K views
Protect your health: retatrutide is being studied in clinical trials and hasn’t been approved for sale to consumers. You don’t know what’s in black-market unapproved “reta.” Don’t take the risk. Learn more: https://t.co/xxCKielaDj
41.6K views
Adults with type 2 diabetes on our investigational triple agonist saw significant A1C reductions at 40 weeks in the TRANSCEND-T2D-1 trial. Results presented today at #ADA2026 and published simultaneously in @TheLancet. Read more: https://t.co/1Wx2P7saq2
10.5K views
New data: Our oral GLP-1 delivered superior A1C control and weight loss across three clinical trials. Read more: https://t.co/GuyV2Jv4iE #ADA2026
8.4K views
In a late-breaking oral presentation, Lilly shared Phase 3 study results for one of our medicines as part of a time-limited regimen in chronic lymphocytic leukemia (#CLL).
Learn more here: https://t.co/tIp1skLgXe
📊 Post performance
🔥 Top post: Protect your health: retatrutide is being studied in clinical tr · 47.2K views
📊 Activity & format
Recent posts
View on X ↗
🔥 Top post
Protect your health: retatrutide is being studied in clinical trials and hasn’t been approved for sale to consumers. You don’t know what’s in black-market unapproved “reta.” Don’t take the risk. Learn more: https://t.co/xxCKielaDj
Lilly’s injectable weight management medicine was linked to lower healthcare costs over time compared to those not on treatment. Read more from this new study: https://t.co/89ogjfCqfL
Helping more patients, growing our business, advancing our innovative pipeline, expanding for the future – our second quarter results continued to build momentum in a strong 2026. Read more: https://t.co/olKPDyRiSK
A Breakthrough Therapy designation granted by the @FDA will help advance a potential treatment option that could be meaningful for previously treated patients with a certain form of advanced #pancreaticcancer.
Learn more: https://t.co/nNU…
Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist.
Learn more: https://t.co/YZ6AWs9FqL
▶
Innovation is redefining what’s possible in retinal disease, and we’re working every day to advance progress in ophthalmology research to help people living with wet age-related macular degeneration.
Emerging research could offer a new approach to treatment-resistant depression. Read more on our agreement to acquire AtaiBeckley, a clinical-stage company developing innovative medicines for mental health conditions. https://t.co/vzLMH0d9…
A new pathway for access to obesity treatment through Medicare begins July 1. Eligible Medicare Part D patients may be able to get certain medicines for weight management through Medicare GLP-1 Bridge.
Learn more and see the CMS Medicare…
In a late-breaking oral presentation, Lilly shared Phase 3 study results for one of our medicines as part of a time-limited regimen in chronic lymphocytic leukemia (#CLL).
Learn more here: https://t.co/tIp1skLgXe
In an oral presentation at #EHA2026, initial clinical results will be shared from a Phase 1 study evaluating a first-in-class therapy in previously treated myelofibrosis.
Learn more here: https://t.co/3ylZ3ZWTrr
The @US_FDA has approved a new dosing option for Lilly’s moderate-to-severe atopic dermatitis (#eczema) treatment. Learn more about what this may mean for patients: https://t.co/JHc16JSo5u
💡 Facts
🕵️ Fake follower check
Estimated- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~3.4% of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (16+ years old).
- 0.04% engagement — below the ~14.4% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
More like this
Find more →Frequently asked questions
How much does Eli Lilly and Company charge for a sponsorship?
How do I contact Eli Lilly and Company for a brand deal or collaboration?
How many followers does Eli Lilly and Company have?
✉ Message Eli Lilly and Company
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Eli Lilly and Company
Booking an event / appearance is a Pro feature. Upgrade to book Eli Lilly and Company for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Eli Lilly and Company gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove